Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Cyclosporin Therapy in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response (DermAtOmics)

NCT05692843 is registered in ClinicalTrials.gov with Instituto de Investigación Hospital Universitario La Paz as lead sponsor.

NCT NCT05692843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05692843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Cyclosporin Therapy in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response (DermAtOmics)
Lead sponsor
Instituto de Investigación Hospital Universitario La Paz
Phase
Phase 4
Overall status
Unknown status
Start date
October 10, 2022
Completion date
July 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis